Your browser doesn't support javascript.
loading
Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19 : A Binational Cohort Study.
Kim, Min Seo; Lee, Hayeon; Lee, Seung Won; Kwon, Rosie; Rhee, Sang Youl; Lee, Jin A; Koyanagi, Ai; Smith, Lee; Fond, Guillaume; Boyer, Laurent; Lee, Jinseok; Rahmati, Masoud; Shin, Ju-Young; Min, Chanyang; Shin, Jae Il; Yon, Dong Keon.
Affiliation
  • Kim MS; Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts (M.S.K.).
  • Lee H; Department of Biomedical Engineering, Kyung Hee University, Yongin, South Korea, and Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea (H.L.).
  • Lee SW; Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, South Korea (S.W.L.).
  • Kwon R; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea (R.K., C.M.).
  • Rhee SY; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, and Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, South Korea (S.Y.R.).
  • Lee JA; Department of Biomedical Engineering, Kyung Hee University, Yongin, South Korea (J.A.L., J.L.).
  • Koyanagi A; Research and Development Unit, Parc Sanitari Sant Joan de Deu, Barcelona, Spain (A.K.).
  • Smith L; Centre for Health, Performance and Wellbeing, Anglia Ruskin University, Cambridge, United Kingdom (L.S.).
  • Fond G; Research Centre on Health Services and Quality of Life, Assistance Publique-Hôpitaux de Marseille, Aix Marseille University, Marseille, France (G.F., L.B.).
  • Boyer L; Research Centre on Health Services and Quality of Life, Assistance Publique-Hôpitaux de Marseille, Aix Marseille University, Marseille, France (G.F., L.B.).
  • Lee J; Department of Biomedical Engineering, Kyung Hee University, Yongin, South Korea (J.A.L., J.L.).
  • Rahmati M; Department of Physical Education and Sport Sciences, Faculty of Literature and Human Sciences, Lorestan University, Khorramabad, Iran, and Department of Physical Education and Sport Sciences, Faculty of Literature and Humanities, Vali-e-Asr University of Rafsanjan, Rafsanjan, Iran (M.R.).
  • Shin JY; School of Pharmacy, Sungkyunkwan University, Suwon, South Korea (J.-Y.S.).
  • Min C; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea (R.K., C.M.).
  • Shin JI; Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea (J.I.S.).
  • Yon DK; Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine; Department of Pediatrics, Kyung Hee University Medical Center, Kyung Hee University College of Medicine; and Department of Regulatory Science, Kyung Hee University, Seoul, South Korea (D.K.Y.).
Ann Intern Med ; 177(3): 291-302, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38437702
ABSTRACT

BACKGROUND:

Some data suggest a higher incidence of diagnosis of autoimmune inflammatory rheumatic diseases (AIRDs) among patients with a history of COVID-19 compared with uninfected patients. However, these studies had methodological shortcomings.

OBJECTIVE:

To investigate the effect of COVID-19 on long-term risk for incident AIRD over various follow-up periods.

DESIGN:

Binational, longitudinal, propensity-matched cohort study.

SETTING:

Nationwide claims-based databases in South Korea (K-COV-N cohort) and Japan (JMDC cohort).

PARTICIPANTS:

10 027 506 Korean and 12 218 680 Japanese patients aged 20 years or older, including those with COVID-19 between 1 January 2020 and 31 December 2021, matched to patients with influenza infection and to uninfected control patients. MEASUREMENTS The primary outcome was onset of AIRD (per appropriate codes from the International Classification of Diseases, 10th Revision) 1, 6, and 12 months after COVID-19 or influenza infection or the respective matched index date of uninfected control patients.

RESULTS:

Between 2020 and 2021, among the 10 027 506 Korean participants (mean age, 48.4 years [SD, 13.4]; 50.1% men), 394 274 (3.9%) and 98 596 (0.98%) had a history of COVID-19 or influenza, respectively. After propensity score matching, beyond the first 30 days after infection, patients with COVID-19 were at increased risk for incident AIRD compared with uninfected patients (adjusted hazard ratio, 1.25 [95% CI, 1.18 to 1.31]) and influenza-infected control patients (adjusted hazard ratio, 1.30 [CI, 1.02 to 1.59]). The risk for incident AIRD was higher with more severe acute COVID-19. Similar patterns were observed in the Japanese cohort.

LIMITATIONS:

Referral bias due to the pandemic; residual confounding.

CONCLUSION:

SARS-CoV-2 infection was associated with increased risk for incident AIRD compared with matched patients without SARS-CoV-2 infection or with influenza infection. The risk for incident AIRD was higher with greater severity of acute COVID-19. PRIMARY FUNDING SOURCE National Research Foundation of Korea.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza, Human / COVID-19 Limits: Female / Humans / Male / Middle aged Language: En Journal: Ann Intern Med Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza, Human / COVID-19 Limits: Female / Humans / Male / Middle aged Language: En Journal: Ann Intern Med Year: 2024 Type: Article